ALAMEDA, Calif. (AP) _ BioTime Inc. (BTX) on Thursday reported a loss of $45 million in its fourth quarter.
The Alameda, California-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share.
The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 7 cents per share.
The biotechnology company posted revenue of $758,000 in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $743,000.
For the year, the company reported that its loss widened to $46 million, or 36 cents per share. Revenue was reported as $5 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BTX at https://www.zacks.com/ap/BTX